Interakcje lekow roslinnych stosowanych w chorobach ukladu oddechowego

• Autorzy: Blecharz-Klin K , Piechal A. , Pyrzanowska J. , Widy-Tyszkiewicz E.
• Języki publikacji: PL

Abstrakty

PL

Herbs are often used in therapies of respiratory system disorders. Concurrent use of con­ventional drugs enhance the risk of revealing herb-drug interactions. The review deals with the most popular herbal remedies supporting the results of clinical trials and the preclinical experiments as well. Common drug interactions that have potential clinical significance in respiratory diseases are discussed.

EN

Leki roślinne są często stosowane w terapii schorzeń układu oddechowego. Gdy są przyj­mowanie jednocześnie z lekami konwencjonalnymi, zwiększa to ryzyko wystąpienia inter­akcji ze składnikami farmakologicznie czynnymi roślin leczniczych. Na podstawie zarówno wyników badań klinicznych, jak i doświadczeń przedklinicznych omówiono najczęściej używane preparaty pochodzenia roślinnego. Przedstawiono najczęstsze interakcje wpływające w znacznym stopniu na przebieg terapii schorzeń układu oddechowego.

Słowa kluczowe

PL

dzialanie antagonistyczne; dzialania niepozadane; leki roslinne; interakcje; dzialanie lekow; farmakologia; dzialanie synergistyczne; choroby ukladu oddechowego

• Wydawca: -
• Czasopismo: Herba Polonica
• Rocznik: 2005
• Tom: 51
• Numer: 3-4
• Opis fizyczny: s.87-105,tab.,bibliogr.

Twórcy

autor

Blecharz-Klin K

• Akademia Medyczna, Krakowskie Przedmiescie 26/28, 00-927 Warszawa

autor

Piechal A.

autor

Pyrzanowska J.

autor

Widy-Tyszkiewicz E.

Bibliografia

• 1. Abebe W. Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharm Ther 2002; 27(6):391-401.
• 2. Hu Z, Yang X, Ho PC, Chan SY, Heng PW, Chan E et al. Herb-drug interactions: a literature review. Drugs 2005; 65(9): 1239-82.
• 3. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001; 61(15):2163-75.
• 4. Chen HW, Yang jj, Tsai CW, Wu JJ, Sheen LY, Ou CC et al. Dietary fat and garlic oil independently regulate hepatic cytochrome p(450) 2B1 and the placental form of glutathione S-transferase expression in rats. J Nutr 2001; l31(5):l438-43.
• 5. Wang EJ, Li Y, Lin M, Chen L, Stein AP, Reuhl KR et al. Protective effects of garlic and related organosulfur compounds on acetaminophen-induced hepatotoxicity in mice. Toxicol Appl Pharmacol 1996; 136(1): 146-154.
• 6. Awang DVC, Fugh-Berman A. Herbal interactions with cardiovascular drugs. Cardiovasc Nurs 2002; 16(4):64-70.
• 7. Sunter WH. Warfarin and garlic. PharmJ 1991; 246:722.
• 8. Vaes LP, Chyka PA. Interactions of warfarin with garlic, ginger, ginkgo or ginseng: nature of the evidence. Ann Pharmacother 2000; 34(12):1478-82.
• 9. Rose KD, Croissant PD, Parliament CF, Levin MB. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report. Neurosurgery 1990; 26(5):880-2.
• 10. Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA 2001; 286(2):208-16.
• 11. Briggs WH, Xiao H, Parkin KL, Shen C, Goldman IL. Differential inhibition of human platelet aggregation by selected Allium thiosulfinates. J Agrie Food Chem 2000; 48(11):5731-5.
• 12. Markowitz JS, Devane CL, Chavin KD, Taylor RM, Rúan Y, Donovan JL. Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers. Clin Pharmacol Ther 2003; 74(2):170-7.
• 13. Piscitelli SC, Burstein AH, Weiden N, Gallicano K, Falloon J. Garlic supplements decrease saquinavir plasma concentrations. In: 8th Conference on Retroviruses and Opportunistic Infections; 2001 Feb 4-8; Chicago, USA. 2001: Abstract 743.
• 14. Piscitelli SC, Burstein AH, Weiden N, Gallicano K, Falloon J. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 2002; 34(2):234-8.
• 15. Gallicano K, Foster B, Choudri S. Effect of short-term administration of garlic supplements on single- dose ritonavir pharmacokinetics in healthy volunteers. Br J Clin Pharmacol 2003; 55(2):199-202.
• 16. Laroche M, Choudhri S, Gallicano K, Foster B. Severe gastrointestinal toxicity with concomitant ingestion of ritonavir and garlic. In: Program and Abstracts of the Canadian Association for HIV Research Seventh Annual Canadian Conference on HIV/AIDS; 1998 Apr 30-May 3; Quebec City, Canada. 1998: Abstract 47 IP.
• 17. McCoubrie M. Doctors as patients: lisinopril and garlic. BrJ Gen Pract 1996; 46(403):107.
• 18. Osterhoudt KC, Lee SK, Callahan JM, Henretig FM. Catnip and the alteration ofhuman consciousnes. Vet Human Toxicol 1997; 39(6):373-5.
• 19. Arya SC. Controlling angiotensin-converting-enzyme-inhibitor induced cough by fennel fruit. Ind J Pharm 1999; 31(2):159.
• 20. Zhu M, Wong PY, Li RC. Effect of oral administration of fennel (Foeniculum vulgare) on ciprofloxacin absorption and disposition in the rat. J Pharm Pharmacol 1999; 51(12):1391-96.
• 21. Burkhard PR, Burkhardt K, Haenggeli CA, Landis T. Plant-induced seizures: reappearance of an old problem. J Neurol 1999; 246(8):667-70.
• 22. Jensen-Jarolim E, Leitner A, Hirschwehr R, Kraft D, Wuthrich B, Scheiner O et al. Characterization of allergens in Apiaceae spices: anise, fennel, coriander and cumin. Clin Exp Allergy 1997; 27(11):1299- 306.
• 23. Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drug- herb interactions. Arch Intern Med 1998; 158(20):2200-11.
• 24. Budziński J, Foster B, Vandenhoek S, Amason JT. An in vitro evaluation ofhuman cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000; 7(4):273-82.
• 25. Górski JC, Huang SM, Pinto A, Hamman MA, HilligossJK, Zaheer NA et al. The effect of echinacea (Echinacea purpura root) on cytochrome P 450 activity in vivo. Clin Pharmacol Ther 2004; 75(1):89-100.
• 26. Mullins RJ, Heddle R. Adverse reactions associated with echinacea: the Australian experience. Ann Allergy Asthma Immunol 2002; 88(1);42-51.
• 27. Janetsky K, Morreale A. Probable interaction between warfarin and ginseng. Am J Health Syst Pharm 1997; 54(6):692-3.
• 28. Lumb AB. Effect of dried ginger on human platelet function. Thromb Haemost 1994; 71(1):110-11.
• 29. Janssen PL, Meyboom S, van Staveran WA, de Vegt F, Katan MB. Consumption of ginger (Zingiber officinale roscoe) does not affect ex vivo platelet thromboxane production in humans. Eur J Clin Nutr 1996; 50(11):772-4.
• 30. Bordia A, Verma SK, Srivastava KC. Effect of ginger (Zingiber officinalis Rose.) and fenugreek (Trigonella foenum-graecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 1997; 56(5):379-84.
• 31. Dorso CR, Levin RI, Eldor AJaffe EA, Weksler BB. Chinese food and platelets. N EnglJ Med 1980; 303(13):756-7.
• 32. Sakai K, Oshima N, Kutsuna T, Miyazaki Y, Nakajima H, Muraoka T et al. [Pharmaceutical studies« I crude drugs. I. Effect of the Zingiberaceae crude drug extracts on sulfaguanidine absorption from rat small intestine]. Yakugaku Zasshi 1986; 106(10):947-50.
• 33. Dawson JK, Earnshaw SM, Graham CS. Dangerous monoamine oxidase inhibitor interactions are still occurring in the 1990s. J Accid Emerg Med 1995; 12(1):49-51.
• 34. Hoffman BB, Lefkowitz RJ. Catecholamines, sympathomimetic drugs, and adrenergic receptors antagonists. In: HardmanJG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A, eds. Goodman and Gilman's the Pharmacological Basis of Therapeutics. 9th ed. New York, McGraw Hill, 1996:199-248.
• 35. Pies R. Adverse neuropsychiatrie reactions to herbal and over-the-counter "antidepressants". J Qm I Psychiatry 2000; 61(ll):815-20.
• 36. Skop BP, FinkelsteinJA, Mareth TR, Magoon MR, Brown TM. The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease. Am J Emerg Med 1994; 12(6):6424.
• 37. Anastasio GD, Harston PR. Fetal tachycardia associated with maternal use of pseudoephedrine and OTC oral decongestant. J Am Board Family Practice 1992; 5(5):527-8.
• 38. Mortimer EAJr. Drug toxicity from breast milk? Pediatrics 1977; 60(5):780-l.
• 39. Blumenthal M. Interactions between herbs and conventional drugs, introductory considerations. Herbalgram 2000; 49:52-63.
• 40. ESCOP Monographs. The scientyfic Foundation for Herbal Medicinal Products. 2nd ed. Stuttgart: Georg Thieme Verlag, 2003:14-25, 32-5, 43-7, 48-51, 129-36, 383-7.
• 41. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with ší dietary supplements containing ephedra alkaloids. N Engl J Med 2000; 343(25):1833-8.
• 42. Cupp MJ. Herbal remedies: adverse effects and drug interactions. Am Fam Physician 1999; 59(5):1239-45.
• 43. Fisher CRJr, Veronneau SJ. Herbal preparations: a primer for the aeromedical physician. Aviat Space Environ Med 2000; 71(l):45-60.
• 44. Aslam M, Stockley IH. Interaction between curry ingredient (karela) and drug (chlorpropamide). Lancet 1979; 1(8166):607.
• 45. Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm 2000; 57(13): 1221-7.
• 46. Menendez JA, Ropero S, del Barbacid MM, Montero S, Solanas M, Escrich E et al. Synergistic interaction between vinorelbine and gamma-linolenic acid in breast cancer cells. Breast Cancer Res Treat. 2002; 72(3):203-19.
• 47. Kenny F, Pinder S, Ellis I, Gee J, Nicholson R, Bryce R et al. Gamma linolenic acid with tamoxifen as primary therapy in breast cancer. Int J Cancer 2000:85(5):643-8.
• 48. Ramelet AA, Buchheim G, Lorenz P, Imfeld M. Homeopathic Arnica in postoperative haematomas: a double-blind study. Dermatology 2000; 201(4):347-348.
• 49. Sherman D, Fish D. Management of protease inhibitor-associated diarrhea. Clin Infect Dis 2000; 30(6):908-914.
• 50. Subarnas A, Tadano T, Oshima Y, Kisara K, Ohizumi Y. Pharmacological properties of beta-amyrin palmitate, a novel centrally acting compound, isolated from Lobelia inßata leaves. J Pharm Pharmacol 1993; 45(6):545-50.
• 51. Subarnas A, Tadano T, Nakahata N, Arai Y, Kinemuchi H, Oshima Y et al. A possible mechanism of antidepressant activity of beta-amyrin palmitate isolated from Lobelia inflata leaves in the forced swimming test. Life Sei 1993; 52(3):289-96.
• 52. Hecker M, Runkel F, Voelp A. Behandlung chronischer bronchitis mit einem spezialextrakt aus Efeublattern - multizentrische avendungbeobachtung mit 1350 patienten. Forsch Komplementarmed Klass Naturheilkd 2002; 9(2):77-84.
• 53. Fugh-Berman A. Herb-drug interactions. Lancet 2000; 355(9198):134-8.
• 54. Loi CM, Parker BM, Cusack BJ, Vestal RE. Aging and drug interactions. III. Individual and combined effects of Cimetidine and Cimetidine and ciprofloxacin on theophylline metabolism in healthy male and female nonsmokers. J Pharmacol Exp Ther 1997; 280(2):627-37.
• 55. Tjia JF, Colbert J, Back DJ. Theophylline metabolism in human liver microsomes: inhibition studies. J Pharmacol Exp Ther 1996; 276(3):912-7.
• 56. Kobayashi Y, Sakai R, Ohshiro N, Ohbayashi M, Kohyama N, Yamamoto T. Possible involvement of organic anion transporter 2 on the interaction of theophylline with erythromycin in the human liver. Drug Metab Dispos 2005; 33(5):619-22.
• 57. Martindale. The Complete Drug Reference. 33rd ed. London: Pharmaceutical Press, 2004:761-86.
• 58. Micromedex Healthcare Series. AltMedDex'System; 2002.
• 59. Upton RA. Pharmacokinetic interactions between theophylline and other medication (Part I). Clin Pharmacokinet 1991; 20(l):66-80.
• 60. Upton RA. Pharmacokinetic interactions between theophylline and other medication (Part II). Clin Pharmacokinet 1991; 20(2):135-50.
• 61. DelafuenteJC. Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol 2003; 48(2):133-43.
• 62. Shapiro LE, Shear NH. Drug interactions: Proteins, pumps, and P-450s. J Am Acad Dermatol 2002; 47(4):467-84.